The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Acute Intermittent Porphyria (AIP)

Hepatic porphyria with attacks of abdominal pain and neurological features.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Dahiliye (İç Hastalıkları) department. Book Appointment →

What is Acute Intermittent Porphyria (AIP)?

AIP is caused by autosomal dominant mutations in the HMBS gene encoding porphobilinogen (PBG) deaminase, the third enzyme of the haem biosynthetic pathway.

The defect leads to accumulation of neurotoxic precursors aminolevulinic acid (ALA) and PBG when haem demand increases.

Penetrance is low (10-20%); only a minority of carriers develop symptomatic attacks, typically in females aged 18-45 years.

Symptoms

Severe diffuse abdominal pain disproportionate to physical findings (hallmark)
Nausea, vomiting, constipation and ileus
Autonomic features: tachycardia, hypertension, sweating, tremor
Peripheral neuropathy that can progress to flaccid paralysis (motor predominant, may resemble Guillain-Barré)
Neuropsychiatric features: anxiety, insomnia, agitation, confusion, psychosis, seizures
Hyponatraemia secondary to SIADH
Urine darkens on standing (classical sign)
No skin lesions in pure AIP (distinguishes from cutaneous porphyrias)

Risk Factors

Female sex and reproductive years (luteal phase of menstrual cycle as trigger)
Drugs that induce hepatic CYP enzymes: barbiturates, sulfonamides, phenytoin, carbamazepine, valproate, oestrogens
Fasting and crash dieting
Alcohol consumption
Infection, surgery, stress
Family history of porphyria

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Acute attack with severe abdominal pain, autonomic features and confusion is a medical emergency
  • Progressive weakness or limb paralysis suggests neurological involvement and needs urgent inpatient care
  • Patients with known AIP must seek immediate care for any new attack, fever or upcoming surgery
  • Family members of patients with confirmed HMBS mutation need genetic counselling and screening
  • Recurrent attacks require referral to a specialist porphyria centre

Treatment Methods

01
Remove the precipitating cause and treat intercurrent illness
02
Analgesia: opioids are safe (morphine, fentanyl); avoid NSAIDs that may worsen renal function
03
Intravenous human haemin (heme arginate) 3-4 mg/kg daily for 4 days (specific therapy, start early)
04
Glucose loading 300-500 g/day intravenously when haemin is delayed (suppresses ALA-synthase)
05
Manage hyponatraemia, hypertension, tachycardia and seizures (use safe antiepileptics: gabapentin, levetiracetam)
06
Givosiran (RNAi) monthly subcutaneously for patients with 4 or more attacks per year
07
Long-term care: avoid unsafe drugs (consult drug-safety databases), nutritional support, family counselling, surveillance for hepatocellular carcinoma and chronic kidney disease

Which Department to Visit?

You can visit our Dahiliye (İç Hastalıkları) department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Dahiliye (İç Hastalıkları) Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.